New, obscure, impressive, and probably not a cure:
Found this on Twitter and went to the Chinese site and Google Translated it:
"The day after the operation, my mother called out my name" Alzheimer's disease can also be treated surgically
news.csu.edu.cn/info/1061/1...
Source: People's Daily Health Client Number of clicks: 980 times Release time: November 14, 2024 Author: Zhang Shuang
(Reporter Zhang Shuang from People's Daily Health Client) "The next morning after the operation, I pushed open the door of the ward and my mother called my name. At that moment, I felt that my mother was finally back."
This scene, for many Alzheimer's family members, is like a dream scene, but now through surgery, it may really become a reality.
Ningbo Second Hospital, Zhejiang Province, announced on November 8 that the hospital performed deep neck lymphatic-venous anastomosis on a 76-year-old man with moderate Alzheimer's disease, and the symptoms were significantly improved. The follow-up results 2 months after the operation showed that the elderly not only had a significant recovery in memory, but also could communicate normally with people.
People's Daily Health Client reporters noticed that since this year, many domestic tertiary hospitals have carried out similar operations. Does this mean that there is a way to "reverse" Alzheimer's disease?
On September 14, the team led by Guo Zonghui, deputy director of the Department of Microsurgery at Ningbo Second Hospital, performed deep neck lymphatic-venous anastomosis on Aunt Li. Photo from Ningbo Second Hospital
The operation is like a "dredge", clearing away the pathogenic proteins in the brain
"The theoretical basis of deep neck lymphatic-venous anastomosis is the abnormal accumulation of Aβ-amyloid protein and abnormal phosphorylation of tau protein in the brain, which are two important causes of Alzheimer's disease." On November 11, Guo Zonghui, deputy director (in charge of work) of the Department of Microsurgery and Repair of Hand Surgery at Ningbo Second Hospital, who performed the operation, told the reporter of the People's Daily Health Client that the operation uses super microsurgery technology to shunt the lymphatic circulation in the meninges, speed up the return of intracerebral lymph through the jugular foramen at the base of the skull, and take away more metabolites in the brain, thereby achieving the goal of possibly reversing brain degenerative lesions and slowing down the progression of the disease.
"It can be simply understood as a mechanical excretion process." Guo Zonghui said that the abnormal accumulation of amyloid protein in the brain of the elderly is like a clogged sewer, and the "waste" cannot be transported out in time. The deep neck lymphatic-venous anastomosis can greatly speed up the removal of "waste" and improve the removal efficiency.
On the morning of November 11, Professor Tang Juyu, director of the Microsurgery Reconstruction Clinical Research Center of Xiangya Hospital of Central South University, had just completed the 42nd deep neck lymphatic-venous anastomosis in the hospital. Because it is a minimally invasive surgery, the patient can get out of bed and move around the next day. Among these 42 patients, in addition to restoring their memories, Tang Juyu also saw that the patients who were originally indifferent and taciturn could communicate with him with laughter during the postoperative follow-up.
On March 12, Professor Tang Juyu, Director of the Microscopic Reconstruction Clinical Research Center of Xiangya Hospital of Central South University, and his team checked the patient's recovery. Xiangya Hospital of Central South University Photo
The immediate effect does not represent the final effect, and large-scale clinical trials are still needed
Although many patients have obvious symptom improvement after surgery, the above experts also believe that this surgery can only provide a new idea for the current treatment of Alzheimer's disease, and the specific effectiveness still needs more research to confirm.
Gao Ping, chief physician of the Department of Neurology of Beijing Hospital, told the reporter of the People's Daily Health Client that there is currently no specific treatment for Alzheimer's disease, and the latest monoclonal antibody drugs with disease-modifying treatment (such as Lencanerizumab (Leyibao) that has been launched in my country) can only delay the progression of the disease to a certain extent. "Because the pathogenesis of the disease has not been fully understood. Although there are many hypotheses and mechanisms involved, there is currently no single hypothesis that can perfectly explain the occurrence and development of the disease. Therefore, the existing drugs or treatments developed for a single mechanism cannot reverse the progression of the disease, let alone completely solve or cure Alzheimer's disease."
"For Alzheimer's disease, we cannot judge the effect of surgery only from the immediate improvement of the patient's symptoms after surgery. The patient needs to undergo multiple tests at different time points after surgery, including neurological evaluation, imaging examination, cerebrospinal fluid examination, etc., in order to finally determine the results." Tang Juyu told reporters.
Guo Zonghui also said that, for example, the patient Aunt Li mentioned above still needs to cooperate with comprehensive treatments such as drugs, physical therapy, rehabilitation, etc. after surgery to continue to control the disease and conduct long-term follow-up. "Surgery can only achieve the effect of clearing the abnormal accumulation of amyloid protein in the brain, but it cannot guarantee that new accumulation will not form in the future."
"Generally speaking, this method is just an attempt and exploration. Its efficacy and safety still need to be verified by large-scale clinical trials. The current surgical results of individual cases cannot fully explain whether the surgery itself is universal." Gao Ping summarized to reporters.
Not all patients can do it, and they need to meet the corresponding indications
Currently, among the 42 patients who have undergone this operation at Xiangya Hospital of Central South University, most of them have MMSE scores below 9 points, are in severe cognitive impairment, and cannot continue to control the disease through drugs. However, for advanced patients, the necrosis of nerve cells in the brain cannot be reversed, which also poses a challenge to the final surgical effect of deep cervical lymphatic-venous anastomosis.
"In addition, even if the patient's family members have a strong desire for surgery, they need to have surgical indications before the surgery can be performed." Tang Juyu specifically pointed out that first, it needs to be confirmed by a neurology specialist; secondly, the patient's Aß-PET and Tau-PET imaging diagnoses must be positive; finally, the patient must undergo a surgical tolerance assessment. If the patient suffers from certain serious underlying diseases, he may not be suitable for this operation.